RRC ID 51965
著者 Uchida H, Hasegawa Y, Takahashi H, Makishima M.
タイトル 1α-Dihydroxyvitamin D3 and Retinoic Acid Increase Nuclear Vitamin D Receptor Expression in Monocytic THP-1 Cells.
ジャーナル Anticancer Res
Abstract BACKGROUND:1α,25-Dihydroxyvitamin D3 [1,25(OH)2D3] and retinoic acid, such as all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9cRA), are known to induce differentiation of myeloid leukemia cells. Combined treatment effectively enhances the differentiation effect, particularly in monocytic leukemia cells. The underlying mechanism of this combined effect remains unknown.
MATERIALS AND METHODS:THP-1 monocytic leukemia cells were treated with 1,25(OH)2D3 in combination with 9cRA, ATRA or selective synthetic ligand for retinoic acid receptor (RAR) or retinoid X receptor (RXR), and the nuclear expression and function of vitamin D receptor (VDR) were examined.
RESULTS:Combined treatment with 1,25(OH)2D3 and RAR ligand, not RXR ligand, effectively increased nuclear VDR expression and induced expression of the VDR target gene cathelicidin antimicrobial peptide (CAMP) in a gene-selective manner.
CONCLUSION:Combination of 1,25(OH)2D3 plus RAR ligand is effective in induction of nuclear VDR expression and of target gene.
巻・号 36(12)
ページ 6297-6301
公開日 2016-12-1
DOI 10.21873/anticanres.11225
PII 36/12/6297
PMID 27919949
MeSH Calcitriol / pharmacology* Cell Line Cell Nucleus / drug effects* Cell Nucleus / metabolism Humans Monocytes / drug effects* Monocytes / metabolism Receptors, Calcitriol / metabolism* Tretinoin / pharmacology*
IF 1.994
引用数 2
リソース情報
ヒト・動物細胞 THP-1(RCB1189)